Valuation: BOIRON

Market Cap 490M 559M 452M 422M 795M 52.87B 813M 5.44B 2.1B 26.08B 2.1B 2.05B 90.55B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 442M 505M 408M 381M 717M 47.7B 733M 4.91B 1.89B 23.53B 1.89B 1.85B 81.7B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week+3.30%
Current month+0.71%
1 month+2.92%
3 months+11.90%
6 months-6.00%
Current year-5.84%
1 week 26.8
Extreme 26.8
28.5
1 month 26.5
Extreme 26.5
29
3 years 20.7
Extreme 20.7
55.3
5 years 20.7
Extreme 20.7
55.3
10 years 20.7
Extreme 20.7
92.03
Manager TitleAgeSince
Chief Executive Officer 56 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Change 5-day change 1-year change 3-year change Capi.($)
-4.26%+3.30%+28.18%-26.56% 558M
+3.26%+0.21%-13.15%-6.35% 12.33B
+5.18%+0.21%-35.64%-57.79% 4.51B
+5.34%+0.26%-12.86%-6.22% 4.11B
+6.00%+3.46%+10.84%-38.89% 3.6B
+6.96%+0.34%+13.92%-15.00% 3.58B
+3.90%+1.85%-8.91%-7.63% 3.44B
+3.32%-2.91%-12.76%-2.91% 2.91B
+5.85%-0.46%-5.88%-24.18% 2.23B
+2.79%-1.04%-12.25%+25.46% 1.6B
Average +4.73%+0.07%-4.85%-16.01% 4.26B
Weighted average by Cap. +4.51%+0.13%-9.57%-15.98%

Financials

2024 2025
Net sales 488M 557M 450M 420M 791M 52.65B 809M 5.42B 2.09B 25.97B 2.09B 2.05B 90.17B 501M 572M 463M 432M 813M 54.11B 832M 5.57B 2.15B 26.69B 2.15B 2.1B 92.68B
Net income 11.34M 12.95M 10.47M 9.77M 18.4M 1.22B 18.82M 126M 48.62M 604M 48.62M 47.55M 2.1B 32.64M 37.28M 30.14M 28.14M 52.97M 3.52B 54.18M 363M 140M 1.74B 140M 137M 6.04B
Net Debt -49.74M -56.8M -45.92M -42.88M -80.72M -5.37B -82.55M -553M -213M -2.65B -213M -209M -9.2B -47.86M -54.65M -44.18M -41.25M -77.66M -5.17B -79.43M -532M -205M -2.55B -205M -201M -8.85B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
-
Date Price Change
26-06-29 27.00 -4.26%
26-06-26 €28.20 +2.17%
26-06-25 €27.60 +0.73%
26-06-24 €27.40 -1.79%
26-06-23 €27.90 +1.82%

Annual profits - Rate of surprise